{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-011140","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2022-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.873371+00:00","generated_at":"2026-06-24T08:07:01.160452+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Teladoc Health reports Q2 revenue $592M (+18% YoY) but net loss $3.1B on $3.0B goodwill impairment","bullets":["Revenue $592.4M (+18% YoY); net loss per share $19.22, mainly from $3.0B non-cash goodwill impairment.","Adjusted EBITDA $46.7M, down 30% YoY from $66.8M.","CEO Jason Gorevic cited solid results and Primary360 momentum but noted macroeconomic uncertainty.","Six-month revenue $1.16B (+21% YoY); net loss $9.78B."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-011140","json":"https://secwatch.observer/filing/0001558370-22-011140.json","markdown":"https://secwatch.observer/filing/0001558370-22-011140.md","text":"https://secwatch.observer/filing/0001558370-22-011140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/0001558370-22-011140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000155837022011140/tdoc-20220727x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T08:07:01.160452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}